All chips on life sciences
Sofinnova Ventures closes oversubscribed $440M for dedicated life sciences fund
Sofinnova Ventures was to announce on Monday this week that it closed an oversubscribed $440 million fund, its first dedicated entirely to life sciences.
Sofinnova's eighth fund initially had a $325 million target, with an original hard cap of $400 million, the firm's James Healy told BioCentury.
Recent exits helped the firm reach a first close of $250 million in late June/early July after only four months of fundraising, with a final close four months later, he said.
"Generating returns within